{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:10Z","timestamp":1781636170143,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus L\u00fcbeck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hematopoietic clonal disorders have previously been associated with cardiac diseases. Higher incidences of aortic valve stenosis have been observed not only in clonal hematopoiesis of indeterminate potential (CHIP) but also in monoclonal gammopathy of unknown significance (MGUS). However, studies investigating the outcome after transcatheter aortic valve implantation (TAVI) in MGUS are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Investigate overall survival in MGUS patients after TAVI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the federated real-world data platform TriNetX to identify MGUS patients undergoing TAVI. Patients were divided into cohorts based on presence of MGUS, age or comorbidities and matched using the TriNetX propensity score matching tool. Overall survival was assessed after 1, 3 and 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 58,796 patients with TAVI procedure. Of these, 1039 patients (1.8%) were identified with co-occurring MGUS. Our study shows superior overall survival for patients without MGUS after TAVI in the overall cohort (HR:0.792 CI95% 0.657, 0.954,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014) and &gt;\u200975 years of age (HR:0.797, CI95% 0.660, 0.961,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017) at the 5-year timepoint. 5-year overall survival did not differ in younger MGUS patients (&lt;\u200975 years) or patients with co-occurring chronic kidney disease, chronic obstructive pulmonary disease or heart failure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this real-world analysis in patients with MGUS undergoing TAVI, MGUS was associated with inferior outcomes after TAVI, especially for older (&gt;\u200975 years) patients. Five-year overall survival did not differ among patients with common comorbidities. Our results suggest that MGUS may be linked to worse overall long-term survival following TAVI and highlights the need for further interdisciplinary cardiooncology research. Given the key methodological limitations, the present results should be considered as hypothesis-generating.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-026-00456-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:36:36Z","timestamp":1771551396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival in patients with monoclonal gammopathy of unknown significance after transcatheter aortic valve replacement: a global retrospective propensity-matched real-world analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Lorenz","family":"Oelschl\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Rebafka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Frerker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stiermaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Morf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vorwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Traub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"von Bubnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Khandanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"11","key":"456_CR1","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jacbts.2023.04.010","volume":"8","author":"F Lassalle","year":"2023","unstructured":"Lassalle F, Duployez N, Vincent F, Rauch A, Denimal T, Rosa M. Negative impact of TET2 mutations on Long-Term survival after transcatheter aortic valve Replacement. JACC Basic Transl Sc. 2023;8(11):1424\u201335.","journal-title":"JACC Basic Transl Sc"},{"issue":"4","key":"456_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","volume":"74","author":"P Libby","year":"2019","unstructured":"Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J. u. a. Clonal hematopoiesis. J Am Coll Cardiol Juli. 2019;74(4):567\u201377.","journal-title":"J Am Coll Cardiol Juli"},{"issue":"20","key":"456_CR3","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","volume":"81","author":"ED Gumuser","year":"2023","unstructured":"Gumuser ED, Schuermans A, Cho SMJ, Sporn ZA, Uddin MM, Paruchuri K. u. a. Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol Mai. 2023;81(20):1996\u20132009.","journal-title":"J Am Coll Cardiol Mai"},{"issue":"7","key":"456_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J. u. a. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 12 Februar. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J 12 Februar"},{"issue":"8","key":"456_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4244\/EIJ-D-23-00232","volume":"19","author":"M Seiffert","year":"2023","unstructured":"Seiffert M, Vonthein R, Baumgartner H, Borger MA, Choi YH, Falk V. u. a. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE trial. EuroIntervention Oktober. 2023;19(8):652\u20138.","journal-title":"EuroIntervention Oktober"},{"issue":"18","key":"456_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M. u. a. Transcatheter Aortic-Valve replacement with a Balloon-Expandable valve in Low-Risk patients. N Engl J Med 2 Mai. 2019;380(18):1695\u2013705.","journal-title":"N Engl J Med 2 Mai"},{"issue":"18","key":"456_CR7","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O\u2019Hair D. u. a. Transcatheter Aortic-Valve replacement with a Self-Expanding valve in Low-Risk patients. N Engl J Med 2 Mai. 2019;380(18):1706\u201315.","journal-title":"N Engl J Med 2 Mai"},{"issue":"8","key":"456_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF. u. a. A Long-Term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 21 Februar. 2002;346(8):564\u20139.","journal-title":"N Engl J Med 21 Februar"},{"issue":"22","key":"456_CR9","first-page":"5412","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB. u. a. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 28 Mai. 2009;113(22):5412\u20137.","journal-title":"Blood 28 Mai"},{"issue":"3","key":"456_CR10","first-page":"313","volume":"4","author":"B Schwartz","year":"2022","unstructured":"Schwartz B, Schou M, Ruberg FL, Rucker D, Choi J, Siddiqi O. u. a. Cardiovascular morbidity in monoclonal gammopathy of undetermined significance. JACC: CardioOncology September. 2022;4(3):313\u201322.","journal-title":"JACC: CardioOncology September"},{"issue":"Supplement 1","key":"456_CR11","first-page":"6765","volume":"142","author":"G Araji","year":"2023","unstructured":"Araji G, Mustafa A, Wei C, Niazi M, Grovu R, Weinberg M. u. a. Monoclonal gammopathy of undetermined significance and associated cardiovascular outcomes in a hospital Setting - a fresh perspective. Blood 2 November. 2023;142(Supplement 1):6765\u20136765.","journal-title":"Blood 2 November"},{"issue":"2","key":"456_CR12","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN. u. a. A global federated real-world data and analytics platform for research. JAMIA Open 6 April. 2023;6(2):ooad035.","journal-title":"JAMIA Open 6 April"},{"issue":"7","key":"456_CR13","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cancers16071416","volume":"16","author":"M Von Kappenstein","year":"2024","unstructured":"Kappenstein M, Von Bubnoff N. Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores. Cancers. 2024;16(7):1416.","journal-title":"Cancers"},{"issue":"2","key":"456_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry Februar. 2021;8(2):130\u201340.","journal-title":"Lancet Psychiatry Februar"},{"key":"456_CR15","doi-asserted-by":"publisher","first-page":"106606","DOI":"10.1016\/j.rmed.2021.106606","volume":"188","author":"YB Hadi","year":"2021","unstructured":"Hadi YB, Lakhani DA, Naqvi SF, Fatima NU, Sarwari AR. Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study. Respiratory Med November. 2021;188:106606.","journal-title":"Respiratory Med November"},{"issue":"2","key":"456_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ehjqcco\/qcac021","volume":"9","author":"D Delijani","year":"2023","unstructured":"Delijani D, Li L, Rutkin B, Wilson S, Kennedy KF, Hartman AR. u. a. Impact of age on outcomes after transcatheter aortic valve implantation. Eur Heart J - Qual Care Clin Outcomes 28 Februar. 2023;9(2):135\u201341.","journal-title":"Eur Heart J - Qual Care Clin Outcomes 28 Februar"},{"issue":"1","key":"456_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.amjcard.2013.09.044","volume":"113","author":"O Havakuk","year":"2014","unstructured":"Havakuk O, Finkelstein A, Steinvil A, Halkin A, Arbel Y, Abramowitz Y. u. a. Comparison of outcomes in Patients\u2009\u2264\u200985 versus >\u200985 years of age undergoing transcatheter Aortic-Valve implantation. Am J Cardiol Januar. 2014;113(1):138\u201341.","journal-title":"Am J Cardiol Januar"},{"issue":"13","key":"456_CR18","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.4244\/EIJ-D-17-00421","volume":"13","author":"M Arsalan","year":"2018","unstructured":"Arsalan M, Weferling M, Hecker F, Filardo G, Kim WK, Pollock B. u. a. TAVI risk scoring using established versus new scoring systems: role of the new STS\/ACC model. EuroInterv. 2018;13(13):1520\u20136.","journal-title":"EuroInterv"},{"issue":"2","key":"456_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E. u. a. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 13 Juli. 2017;377(2):111\u201321.","journal-title":"N Engl J Med 13 Juli"},{"issue":"19","key":"456_CR20","doi-asserted-by":"publisher","first-page":"e180066","DOI":"10.1172\/JCI180066","volume":"134","author":"O Oren","year":"2024","unstructured":"Oren O, Small AM, Libby P. Clonal hematopoiesis and atherosclerosis. J Clin Invest 1 Oktober. 2024;134(19):e180066.","journal-title":"J Clin Invest 1 Oktober"},{"issue":"12","key":"456_CR21","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/ijc.34476","volume":"152","author":"MM Epstein","year":"2023","unstructured":"Epstein MM, Zhou Y, Castaneda-Avila MA, Cohen HJ. Multimorbidity in patients with monoclonal gammopathy of undetermined significance. Intl J Cancer 15 Juni. 2023;152(12):2485\u201392.","journal-title":"Intl J Cancer 15 Juni"},{"issue":"1","key":"456_CR22","doi-asserted-by":"publisher","first-page":"100531","DOI":"10.1016\/j.jscai.2022.100531","volume":"2","author":"B Bhardwaj","year":"2023","unstructured":"Bhardwaj B, Kolte D, Zhao Y, Alu MC, Zahr F, Passeri JJ. u. a. Severity of and recovery from anemia after transcatheter aortic valve replacement: an analysis of the PARTNER trials and registries. J Soc Cardiovasc Angiography Interventions Januar. 2023;2(1):100531.","journal-title":"J Soc Cardiovasc Angiography Interventions Januar"},{"issue":"8","key":"456_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","volume":"41","author":"S Mas-Peiro","year":"2020","unstructured":"Mas-Peiro S, Hoffmann J, Fichtlscherer S, Dorsheimer L, Rieger MA, Dimmeler S. u. a. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart J 21 Februar. 2020;41(8):933\u20139.","journal-title":"Eur Heart J 21 Februar"},{"key":"456_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2017.01347","volume":"8","author":"A Bosseboeuf","year":"2017","unstructured":"Bosseboeuf A, Allain-Maillet S, Mennesson N, Tallet A, Rossi C, Garderet L. u. a. Pro-inflammatory state in monoclonal gammopathy of undetermined significance and in multiple myeloma is characterized by low sialylation of Pathogen-Specific and other monoclonal Immunoglobulins. Front Immunol 19 Oktober. 2017;8:1347.","journal-title":"Front Immunol 19 Oktober"},{"issue":"5","key":"456_CR25","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/ehf2.12837","volume":"7","author":"J Hoffmann","year":"2020","unstructured":"Hoffmann J, Mas-Peiro S, Berkowitsch A, Boeckling F, Rasper T, Pieszko K. u. a. Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation. ESC Heart Fail Oktober. 2020;7(5):2597\u2013610.","journal-title":"ESC Heart Fail Oktober"},{"issue":"2","key":"456_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2141.1995.tb03296.x","volume":"89","author":"L DuVillard","year":"1995","unstructured":"DuVillard L, Guiguet M, Casasnovas R, Caillot D, Monnier-Zeller V, Bernard A. u. a. Diagnostic value of serum IL\u20106 level in monoclonal gammopathies. Br J Haematol Februar. 1995;89(2):243\u20139.","journal-title":"Br J Haematol Februar"},{"issue":"2","key":"456_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00277-016-2859-8","volume":"96","author":"EK Lindqvist","year":"2017","unstructured":"Lindqvist EK, Landgren O, Lund SH, Turesson I, Hultcrantz M, Goldin L. u. a. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study. Ann Hematol Februar. 2017;96(2):261\u20139.","journal-title":"Ann Hematol Februar"},{"issue":"2","key":"456_CR28","first-page":"457","volume":"33","author":"AK Dutta","year":"2019","unstructured":"Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB. u. a. Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leuk Februar. 2019;33(2):457\u201368.","journal-title":"Leuk Februar"},{"key":"456_CR29","doi-asserted-by":"publisher","first-page":"101242","DOI":"10.1016\/j.blre.2024.101242","volume":"68","author":"G Hevroni","year":"2024","unstructured":"Hevroni G, Vattigunta M, Kazandjian D, Coffey D, Diamond B, Maura F. u. a. From MGUS to multiple myeloma: unraveling the unknown of precursor States. Blood Reviews November. 2024;68:101242.","journal-title":"Blood Reviews November"},{"issue":"1","key":"456_CR30","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1038\/s41467-022-33944-z","volume":"13","author":"R Boiarsky","year":"2022","unstructured":"Boiarsky R, Haradhvala NJ, Alberge JB, Sklavenitis-Pistofidis R, Mouhieddine TH, Zavidij O. u. a. Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis. Nat Commun 17 November. 2022;13(1):7040.","journal-title":"Nat Commun 17 November"},{"issue":"5","key":"456_CR31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/ejcts\/ezt114","volume":"43","author":"J Kotting","year":"2013","unstructured":"Kotting J, Schiller W, Beckmann A, Schafer E, Dobler K, Hamm C. u. a. German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardio-Thoracic Surg 1 Mai. 2013;43(5):971\u20137.","journal-title":"Eur J Cardio-Thoracic Surg 1 Mai"},{"issue":"12","key":"456_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12471-012-0327-1","volume":"20","author":"L Noyez","year":"2012","unstructured":"Noyez L, Kievit PC, Van Swieten HA, De Boer MJ. Cardiac operative risk evaluation: the EuroSCORE II, does it make a real difference? Neth Heart J Dezember. 2012;20(12):494\u20138.","journal-title":"Neth Heart J Dezember"},{"issue":"10","key":"456_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV. Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic Review. Mayo Clin Proc. 2010;85(10):933\u201342.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"456_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12872-023-03684-z","volume":"24","author":"M Lorente-Ros","year":"2024","unstructured":"Lorente-Ros M, Das S, Malik A, Romeo FJ, Aguilar-Gallardo JS, Fakhoury M. u. a. In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study. BMC Cardiovasc Disord 3 Januar. 2024;24(1):21.","journal-title":"BMC Cardiovasc Disord 3 Januar"},{"issue":"3","key":"456_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12928-022-00859-x","volume":"37","author":"Y Adachi","year":"2022","unstructured":"Adachi Y, Yamamoto M. The OCEAN-SHD family. Chronic kidney disease and transcatheter aortic valve implantation. Cardiovasc Interv Ther Juli. 2022;37(3):458\u201364.","journal-title":"Cardiovasc Interv Ther Juli"},{"issue":"10","key":"456_CR36","first-page":"1072","volume":"6","author":"M Mok","year":"2013","unstructured":"Mok M, Nombela-Franco L, Dumont E, Urena M, DeLarochelli\u00e8re R, Doyle D. u. a. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve Implantation. JACC: cardiovascular interventions. Oktober. 2013;6(10):1072\u201384.","journal-title":"Oktober"},{"issue":"11","key":"456_CR37","doi-asserted-by":"publisher","first-page":"e0225473","DOI":"10.1371\/journal.pone.0225473","volume":"14","author":"U Fischer-Rasokat","year":"2019","unstructured":"Fischer-Rasokat U, Renker M, Liebetrau C, Weferling M, Rolf A, Doss M. Outcome of patients with heart failure after transcatheter aortic valve implantation. Erdoes G, Herausgeber. PLoS ONE. 2019;14(11):e0225473.","journal-title":"PLoS ONE"},{"issue":"11","key":"456_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00392-013-0596-8","volume":"102","author":"A Sedaghat","year":"2013","unstructured":"Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E. u. a. The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol November. 2013;102(11):821\u20139.","journal-title":"Clin Res Cardiol November"},{"key":"456_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjcard.2021.03.027","volume":"149","author":"K Ishizu","year":"2021","unstructured":"Ishizu K, Shirai S, Isotani A, Hayashi M, Kawaguchi T, Taniguchi T. u. a. Long-Term prognostic value of the society of thoracic surgery risk score in patients undergoing transcatheter aortic valve implantation (From the OCEAN-TAVI Registry). Am J Cardiol Juni. 2021;149:86\u201394.","journal-title":"Am J Cardiol Juni"},{"issue":"2","key":"456_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amjcard.2015.03.061","volume":"116","author":"P Green","year":"2015","unstructured":"Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL. u. a. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER Trial). Am J Cardiol Juli. 2015;116(2):264\u20139.","journal-title":"Am J Cardiol Juli"},{"issue":"Supplement2","key":"456_CR41","doi-asserted-by":"publisher","first-page":"ehad6552221","DOI":"10.1093\/eurheartj\/ehad655.2221","volume":"44","author":"LM Soerensen","year":"2023","unstructured":"Soerensen LM, Petersen JK, Strange JE, Schou M, Koeber L, De Backer O. u. a. NT-pro-BNP pre TAVI and relationship with long-term outcomes. Eur Heart J 9 November. 2023;44(Supplement2):ehad6552221.","journal-title":"Eur Heart J 9 November"},{"issue":"11","key":"456_CR42","doi-asserted-by":"publisher","first-page":"e005417","DOI":"10.1161\/CIRCINTERVENTIONS.117.005417","volume":"10","author":"Y Abramowitz","year":"2017","unstructured":"Abramowitz Y, Vemulapalli S, Chakravarty T, Li Z, Kapadia S, Holmes D, et al. Clinical impact of diabetes mellitus on outcomes after transcatheter aortic valve replacement: insights from the society of thoracic Surgeons\/American college of cardiology transcatheter valve therapy registry. Circ Cardiovasc Interve. 2017;10(11):e005417.","journal-title":"Circ Cardiovasc Interv"},{"issue":"10","key":"456_CR43","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.amjcard.2016.02.040","volume":"117","author":"Y Abramowitz","year":"2016","unstructured":"Abramowitz Y, Jilaihawi H, Chakravarty T, Mangat G, Maeno Y, Kazuno Y. u. a. Impact of diabetes mellitus on outcomes after transcatheter aortic valve implantation. Am J Cardiol Mai. 2016;117(10):1636\u201342.","journal-title":"Am J Cardiol Mai"},{"key":"456_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ahj.2023.04.016","volume":"262","author":"MD Lauridsen","year":"2023","unstructured":"Lauridsen MD, Valentin JB, Strange JE, Jacobsen PA, K\u00f8ber L, Weinreich U. u. a. Mortality in patients with chronic obstructive pulmonary disorder undergoing transcatheter aortic valve replacement: the importance of chronic obstructive pulmonary disease exacerbation. Am Heart J August. 2023;262:100\u20139.","journal-title":"Am Heart J August"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00456-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:32:00Z","timestamp":1781634720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00456-4","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}